Taking back control
Emily Piszton was diagnosed with a type of brain tumour called craniopharyngioma in 2022, aged 11. Now 12, Emily explains how her tumour and its treatment caused her to gain weight, and what she did in response to this.
A parent's view: Embracing support
Claire Crowley’s son, James, was diagnosed with leukaemia in November 2014. She describes the challenges of feeding James while on treatment and the nutrition support he received.
How we are making sure all young patients receive the best nutrition care and support
Dr Mark Brougham and Dr Raquel Revuelta-Iniesta co-chair the Cancer and Nutrition working group for Children and Young People, part of the National Institute for Health and Care Research (NIHR). They tell us more about the group, the importance of nutrition and what research is happening to improve nutrition for patients.
Busting the conspiracy – is there a hidden cure for cancer?
Find out why some people believe there is a hidden cure for cancer, and why we know that this rumour is completely false.
Elsie's story
Elsie was diagnosed with a brain tumour aged seven years old. Her mum, Lucy, shares her story.
CCLG Research Talks: How biobanking supports childhood cancer research
Hear from Dr John Moppett about what the VIVO biobank is and how it supports expert childhood cancer research.
Spotlight on childhood cancer research in Cambridge - what are our experts up to?
In the UK and Ireland, over 100 childhood cancer researchers have been funded through CCLG. But what are they working on? Let's take a trip to Cambridge to find out...
Experiences of young cancer patients sought to improve care
On 23 April 2024, the TYAC Professional Education Group is running a session aimed at helping staff better understand the experiences of young people with cancer as part of Children's Cancer and Leukaemia Group's (CCLG) Annual Conference.
Pioneering research sheds light on immune cells in childhood brain tumours
Childhood cancer researchers looking at the composition of a childhood brain tumour called ependymoma have made a key breakthrough in the way this disease is understood. For years, treatments for ependymoma have seen limited progress, with no major breakthroughs on the horizon for these young...